Pulmatrix (PULM) EBITDA Margin (2014 - 2024)
Pulmatrix's EBITDA Margin came in at -65066.67% for Q4 2024, down 64967.35 percentage points from -99.32% a year earlier and down 64340.71 percentage points from the prior quarter.
Powered by 
Analysis
Pulmatrix (PULM) EBITDA Margin (2014 - 2024) Analysis & Trends
For FY2024, Pulmatrix's EBITDA Margin was -123.71%, up 76.42 percentage points from FY2023.
- EBITDA Margin has increased in each of the last three years, with a five-year change of +135.58 percentage points (FY2019 to FY2024).
- Going back by year, EBITDA Margin was -200.14% in FY2023 (+109.28 pp), -309.42% in FY2022 (+77.46 pp), -386.88% in FY2021 (-310.53 pp) and -76.36% in FY2020 (+182.93 pp).
- The Q4 2024 figure represents the lowest quarterly EBITDA Margin in data going back to Q1 2014.
- Year-over-year, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of -8108.89 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2022 (a gain of 628.01 percentage points), and the weakest in Q4 2024 (a drop of 64967.35 percentage points).
- Business Quant data shows PULM's EBITDA Margin at -725.96% (Q3 2024), -377.19% (Q2 2024) and 13.70% (Q1 2024) in the three quarters before Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Pulmatrix | 5.55 Mn | 5.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -65,066.67% |
| Sep 30, 2024 | -725.96% |
| Jun 30, 2024 | -377.19% |
| Mar 31, 2024 | 13.70% |
| Dec 31, 2023 | -99.32% |
| Sep 30, 2023 | -222.88% |
| Jun 30, 2023 | -214.70% |
| Mar 31, 2023 | -303.74% |
| Dec 31, 2022 | -250.94% |
| Sep 30, 2022 | -270.25% |
| Jun 30, 2022 | -338.99% |
| Mar 31, 2022 | -424.83% |
| Dec 31, 2021 | -878.95% |
| Sep 30, 2021 | -761.83% |
| Jun 30, 2021 | -169.12% |
| Mar 31, 2021 | -290.22% |
| Dec 31, 2020 | -130.80% |
| Sep 30, 2020 | -27.97% |
| Jun 30, 2020 | -32.06% |
| Mar 31, 2020 | -169.66% |
API Access
Pulmatrix EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PULM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PULM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PULM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();